Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: jack w garnes jr. who wrote (13273)	8/13/1998 9:09:00 PM
From: blankmind	Read Replies (1) \| Respond to of 23519

Time will tell. Until we get the 3rd 1/4 results in, who knows whether Vivus ends up at 0 or $100+? - I will say that Vivus is good at keeping its word, e.g. fda approval, new country approvals, astra, getting clobbered by viagra, etc... - question: Will the following trend continue? "Internationally, revenues increased from $2.0 million in the first quarter of 1998 to $9.8 million in the second quarter of 1998..." - If you think so, then hang in there & buy more. If not, then sell short. Good luck.